AU2003250468A8 - A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles - Google Patents

A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles

Info

Publication number
AU2003250468A8
AU2003250468A8 AU2003250468A AU2003250468A AU2003250468A8 AU 2003250468 A8 AU2003250468 A8 AU 2003250468A8 AU 2003250468 A AU2003250468 A AU 2003250468A AU 2003250468 A AU2003250468 A AU 2003250468A AU 2003250468 A8 AU2003250468 A8 AU 2003250468A8
Authority
AU
Australia
Prior art keywords
manufacture
composition containing
multiple units
stable oral
pharamceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003250468A
Other versions
AU2003250468A1 (en
Inventor
Janak Shah Maya
Javed Abdul Sattar Abdul
Narayan Gadkari Parag
Amit Krishna Antarkar
Hasmukhlal Thanawala Gaurang
Ramanlal Shah Janak
Kishore Joshi Ketaki
Ghanshamlal Lala Rajendra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Themis Laboratories Pvt Ltd
Original Assignee
Themis Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Themis Laboratories Pvt Ltd filed Critical Themis Laboratories Pvt Ltd
Publication of AU2003250468A8 publication Critical patent/AU2003250468A8/en
Publication of AU2003250468A1 publication Critical patent/AU2003250468A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AU2003250468A 2002-08-16 2003-08-04 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles Abandoned AU2003250468A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN742/MUM/2002 2002-08-16
IN742MU2002 2002-08-16
PCT/IB2003/003514 WO2004016242A2 (en) 2002-08-16 2003-08-04 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles

Publications (2)

Publication Number Publication Date
AU2003250468A8 true AU2003250468A8 (en) 2004-03-03
AU2003250468A1 AU2003250468A1 (en) 2004-03-03

Family

ID=31726528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003250468A Abandoned AU2003250468A1 (en) 2002-08-16 2003-08-04 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles

Country Status (4)

Country Link
EP (1) EP1530460A2 (en)
AU (1) AU2003250468A1 (en)
CA (1) CA2496044A1 (en)
WO (1) WO2004016242A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258351B1 (en) * 2001-10-17 2013-06-19 Takeda Pharmaceutical Company Limited Granules containing lansoprazole in large amount
AR051654A1 (en) * 2004-11-04 2007-01-31 Astrazeneca Ab NEW FORMULATIONS OF MODIFIED RELEASE PELLETS FOR PROTON PUMP INHIBITORS
AR052225A1 (en) * 2004-11-04 2007-03-07 Astrazeneca Ab FORMULATIONS OF MODIFIED RELEASE TABLETS FOR INHIBITORS OF THE PUMP OF PROTONS
ITMO20050157A1 (en) 2005-06-22 2006-12-23 New Photocatalyst Solution Ltd SUSPENSIONS OF TITANIUM DIOXIDE AND METHOD OF OBTAINING THEM.
CN100425235C (en) * 2006-12-14 2008-10-15 湖南康普制药有限公司 Enteric omeprazole micropill and its preparing method
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
WO2013064535A1 (en) * 2011-11-02 2013-05-10 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical composition of omeprazole
CN103202818A (en) * 2012-01-15 2013-07-17 山东新时代药业有限公司 An enteric-coated tablet containing D-rabeprazole or a pharmaceutically acceptable salt thereof, and a preparation method therefor
CN103550188B (en) * 2013-11-15 2014-10-29 四川智强医药科技开发有限公司 Lansoprazole enteric-coated pellet capsule as well as preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
WO2004016242A3 (en) 2004-04-08
CA2496044A1 (en) 2004-02-26
AU2003250468A1 (en) 2004-03-03
WO2004016242A2 (en) 2004-02-26
WO2004016242A8 (en) 2004-10-07
EP1530460A2 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
GB0201621D0 (en) Process for preparating dental prosthesis
HK1085131A1 (en) Solid drug for oral use
IL200849A0 (en) Pharmaceutical composition comprising bisphosphonate for oral application and a process for its prepatrtion
EP1553925A4 (en) Modified release oral dosage form
GB0225676D0 (en) New use for pharmaceutical composition
EP1532971A4 (en) Compositions for oral cavity
AU2003283870A1 (en) Process for preparing a composition
GB0201617D0 (en) Process for preparating dental prosthesis
AU2003250468A8 (en) A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
HK1072194A1 (en) Oral dosage form for controlled drug release
AU2003252683A8 (en) Composition for oral use
EP1553185A4 (en) Process for producing solution containing ubiquinone-10
AU2003209533A8 (en) Process of manufacturing pharmaceutical composition useful for management of tuberculosis
EP1587792A4 (en) Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
GB0510496D0 (en) Process for producing carbonaceous materials
EP1580191A4 (en) Process for producing carbapenem compound for oral administration
AU2003225745A8 (en) Free-base formulations of local anesthetics
AU2003284786A8 (en) Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2003283937A1 (en) A new oral immediated release dosage form
AU2002356425A8 (en) A process for manufacture of a sustained release composition containing microbe
AU2003262154A8 (en) Polyphosphonate derivatives for toothpaste compositions
SG110170A1 (en) New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
EP1539772A4 (en) Process of making phosphordiamidite compounds
AU2003246603A8 (en) Process for providing a stable crystalline form of salbutamol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase